DTT : 18 Years and Counting…

As Editor-in-Chief of Diabetes Technology & Therapeutics (DTT), I am pleased that the journal continues to grow rapidly, bringing you the most important and relevant articles and commentaries in our field. Several new pharmacotherapies and devices (continuous glucose monitors and insulin pumps) have been added to the armamentarium for treatment of diabetes in the past two decades. The data published in DTT articles are cited frequently in expert diabetes lectures all over the world. In the past decade, submissions have quadrupled, so running a rapid and fair peer-review process is our highest priority and greatest challenge. We are fortunate to have the extraordinary support of Senior Editors Jay Skyler and Irl Hirsch, with very fine work by Ananda (Andy) and Rita Basu, who perform an invaluable role of Associate Editors with tremendous energy and enthusiasm, enabling us to move articles through peer review even more quickly.

DTT has high visibility throughout the world, with readers in over 170 countries. The journal averages nearly 11,000 full-text downloads per month, so if you publish in DTT you can be assured that your article will be widely read.

This special supplement includes the prestigious Advanced Technologies & Treatments for Diabetes (ATTD) 2015 Yearbook, an invaluable resource highlighting and interpreting the most exciting and impactful literature published in the field. Each chapter is authored by a leading international opinion leader and presents a concise summary of the most important articles published from July 2014 to June 2015, with invaluable expert commentary. Publishing the Yearbook in DTT is vital because it means the articles are searchable on PubMed, Google, and other search engines.

I am grateful for the hard work by all of the authors and commend Moshe Phillip's and Tadej Battelino's dedication to organizing this resource for our field on an annual basis in conjunction with their outstanding meeting, The 9^th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2016), to be held in Milan, Italy, February 3–6, 2016.

The abstracts from the meeting are also included in this online supplement, giving readers and attendees a view into new and exciting work in technology and therapeutics.

DTT continues to be the official journal of the ATTD. Our partnership is very productive and effective in aligning the leading conference and the leading journal in the field of new technologies and treatments for diabetes.

I look forward to your ongoing active participation in the journal.